229 related articles for article (PubMed ID: 3089933)
1. Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.
Montaraz JA; Winter AJ
Infect Immun; 1986 Aug; 53(2):245-51. PubMed ID: 3089933
[TBL] [Abstract][Full Text] [Related]
2. Immune response to porin in cattle immunized with whole cell, outer membrane, and outer membrane protein antigens of Brucella abortus combined with trehalose dimycolate and muramyl dipeptide adjuvants.
Winter AJ; Verstreate DR; Hall CE; Jacobson RH; Castleman WL; Meredith MP; McLaughlin CA
Infect Immun; 1983 Dec; 42(3):1159-67. PubMed ID: 6315592
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of natural and synthetic complexes of porin and O polysaccharide as vaccines against Brucella abortus in mice.
Winter AJ; Rowe GE; Duncan JR; Eis MJ; Widom J; Ganem B; Morein B
Infect Immun; 1988 Nov; 56(11):2808-17. PubMed ID: 2844673
[TBL] [Abstract][Full Text] [Related]
4. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs.
Woodard LF; Toone NM; Jasman RL
Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042
[TBL] [Abstract][Full Text] [Related]
5. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
6. Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice.
Winter AJ; Rowe GE
Vet Immunol Immunopathol; 1988 Mar; 18(2):149-63. PubMed ID: 3133872
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. II. Whole cells.
Woodard LF; Toone NM; McLaughlin CA
Can J Comp Med; 1980 Oct; 44(4):456-8. PubMed ID: 6778600
[TBL] [Abstract][Full Text] [Related]
8. Immunopotentiation of cattle vaccinated with a soluble Brucella abortus antigen with low LPS content: an analysis of cellular and humoral immune responses.
Dzata GK; Wyckoff JH; Confer AW
Vet Microbiol; 1991 Sep; 29(1):15-26. PubMed ID: 1835212
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.
Jiménez de Bagüés MP; Elzer PH; Jones SM; Blasco JM; Enright FM; Schurig GG; Winter AJ
Infect Immun; 1994 Nov; 62(11):4990-6. PubMed ID: 7927779
[TBL] [Abstract][Full Text] [Related]
10. Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines.
Woodard LF; Toone NM; McLaughlin CA
Infect Immun; 1980 Nov; 30(2):409-12. PubMed ID: 6777304
[TBL] [Abstract][Full Text] [Related]
11. Effect of Brucella abortus transfer factor in preventing murine brucellosis.
Stevens MG; Pugh GW
FEMS Immunol Med Microbiol; 1995 Jul; 11(4):279-84. PubMed ID: 8541805
[TBL] [Abstract][Full Text] [Related]
12. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
13. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
Gupta S; Singh D; Gupta M; Bhatnagar R
Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
[TBL] [Abstract][Full Text] [Related]
14. Mice immune responses to Brucella abortus heat shock proteins. Use of baculovirus recombinant-expressing whole insect cells, purified Brucella abortus recombinant proteins, and a vaccinia virus recombinant as immunogens.
Bae JE; Schurig GG; Toth TE
Vet Microbiol; 2002 Aug; 88(2):189-202. PubMed ID: 12135637
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. I. Soluble antigens.
Woodard LF; Toone NM; McLaughlin CA
Can J Comp Med; 1980 Oct; 44(4):453-5. PubMed ID: 6778599
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines.
Jiménez de Bagüés MP; Elzer PH; Blasco JM; Marín CM; Gamazo C; Winter AJ
Infect Immun; 1994 Feb; 62(2):632-8. PubMed ID: 8300219
[TBL] [Abstract][Full Text] [Related]
17. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
[TBL] [Abstract][Full Text] [Related]
18. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
Senevirathne A; Hewawaduge C; Lee JH
Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
